Novo Nordisk A/S News Headlines

NVO 
$45.67
*  
0.38
0.83%
Get NVO Alerts
*Delayed - data as of Aug. 28, 2014  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVO After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Novo Nordisk Buys US Manufacturing Plant
8/27/2014 5:37:00 AM - Dow Jones Business News

Novo Nordisk: The Case For Predictability In Earnings
8/26/2014 6:29:00 PM - Seeking Alpha

ADR Shares End Higher; WPP Shares Active
8/26/2014 4:41:00 PM - Dow Jones Business News

Why Investing In U.S. Multinationals Is Not The Same As Investing In Foreign Companies
8/20/2014 2:50:00 PM - Seeking Alpha

Novo Nordisk to Pay Fine, Tresiba in Focus - Analyst Blog
8/19/2014 5:50:00 PM - Zacks.com

Why The Sanofi Deal Is The Best Possible Deal For MannKind Investors
8/11/2014 1:09:00 PM - Seeking Alpha

Novo Nordisk: September 11 Could See A Big U.S. Market Catalyst
8/11/2014 7:34:00 AM - Seeking Alpha

Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales - Analyst Blog
8/8/2014 4:10:00 PM - Zacks.com

Novo Nordisk H1 Profit Up - Quick Facts
8/7/2014 1:54:00 AM - RTT News

European ADRs Contract Despite Positive Eurozone Growth Data -- Edap Gains, CGG Lower
8/5/2014 11:40:21 AM - MT Newswires

Novo Nordisk Diabetes Drug Xultophy Gets Positive CHMP View - Analyst Blog
7/29/2014 8:13:00 AM - Zacks.com

Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2014 Update
7/28/2014 6:12:00 AM - Seeking Alpha

5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise
7/21/2014 9:53:00 AM - Seeking Alpha

The Global Guru: What are the Top Five Global Stock Markets of 2014?
7/9/2014 10:09:28 AM - Eagle Financial Publications

Sanofi's Basal Insulin Candidate Under FDA Review - Analyst Blog
7/8/2014 6:40:00 PM - Zacks.com

Novo Nordisk Gets FDA Nod for NovoSeven RT - Analyst Blog
7/8/2014 11:30:00 AM - Zacks.com

Zafgen Appoints Patrick Loustau As President - Quick Facts
7/1/2014 8:08:00 AM - RTT News

Pre-Market Most Active for Jun 27, 2014 : AAXJ, AMSG, ERIC, BCS, GPRO, BAC, MTW, DSGX, FB, TWTR, NVO, PUK
6/27/2014 8:39:54 AM - NASDAQ.com News

MannKind's Clock Is Ticking, But Balance Sheet Sounds An Alarm
6/27/2014 2:22:00 AM - Seeking Alpha

Novo Nordisk's Diabetes Pill Shows Promise
6/26/2014 6:05:00 PM - Seeking Alpha

Sanofi: Toujeo Is Not The Ace In Its Deck
6/23/2014 4:32:00 PM - Seeking Alpha

Novo Nordisk Reveals Positive Data on Victoza 3 mg - Analyst Blog
6/23/2014 11:30:00 AM - Zacks.com

The Anti-Obesity Space Is Not As Simple As Some Think
6/20/2014 11:34:00 AM - Seeking Alpha

Novo Nordisk (NVO) is in Overbought Territory: What's Next? - Tale of the Tape
6/18/2014 9:46:12 AM - Zacks.com

Ligand Pharma's LGD-6972 Positive in Phase I Study - Analyst Blog
6/17/2014 4:35:00 PM - Zacks.com